Research Involving Human Subjects Institutional Review Board (IRB)

Download Research Involving Human Subjects Institutional Review Board (IRB)

Post on 26-Dec-2015

217 views

Category:

Documents

3 download

Embed Size (px)

TRANSCRIPT

<ul><li> Slide 1 </li> <li> Research Involving Human Subjects Institutional Review Board (IRB) </li> <li> Slide 2 </li> <li> History and Ethical principles Nuremberg Code 1947 Declaration of Helsinki 1964 National Research Act 1974 Belmont Report 1979 Respect for person- Informed consent Beneficence- Favorable benefit-risk ratio Justice- Selection of subjects Public Heath Services Act 1985 </li> <li> Slide 3 </li> <li> Human Subject Protection Regulations DHHS Regulations 45 CFR part 46- Subparts A, B, C, D, &amp; E FDA Regulations 21 CFR part 50, Protection of Human Subjects 21 CFR part 56, Institutional Review Boards 21 CFR part 312, Investigational New Drug Application 21 CFR part 812, Investigational Device Exemptions </li> <li> Slide 4 </li> <li> OU Federal Wide Assurance All research involving the participation of human subjects must be submitted for review by the IRB (Institutional Review Board for the Protection of Human Subjects). </li> <li> Slide 5 </li> <li> DHHS Definition 45 CFR 46.102(d) Research means a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge. </li> <li> Slide 6 </li> <li> DHHS Definition (cntd) 45 CFR 46.102(f) Human subject means a living individual about whom an investigator (whether professional or student) conducting research obtains (1) Data through intervention or interaction with the individual, or (2) Identifiable private information. </li> <li> Slide 7 </li> <li> DHHS Definition (cntd) Private Information: Information about behavior that occurs in a setting in which the individual can reasonably expect that no observation or recording is taking place information that has been provided for specific purposes, other than research, where the individual can reasonably expect that it will not be made public (e.g., a medical record.) [45 CFR 46.102(f)]. Protected Health Identifiers (PHI) </li> <li> Slide 8 </li> <li> DHHS Definition (cntd) Coded Private Information or Biological Specimens DHHS Office of Human Research Protection (OHRP) policy considers private information or specimens to be individually identifiable when they can be linked to specific individuals either directly or indirectly through coding systems. DHHS OHRP guidance states that only a knowledgeable person or entity is authorized to determine if coded specimen or data constitute research. An investigator cannot make that determination. </li> <li> Slide 9 </li> <li> Institutional Review Board IRB is a review committee established to help protect the rights and welfare of human research subjects. Authority of the IRB: Approve, disapprove, or modify research Conduct continuing reviews Observe and verify changes Suspend or terminate approval Observe the consent process and research procedures </li> <li> Slide 10 </li> <li> Review Categories Exempt Expedited Review Full board Review Depends on the Risk Level (physical, psychological, social and economic risk) </li> <li> Slide 11 </li> <li> What is minimal risk? Minimal risk means that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests. </li> <li> Slide 12 </li> <li> Review Categories (cntd) May be Exempt Projects that present no more than minimal risk to the participants and do not compromise the privacy of the participants or confidentiality of the data Fits 1 of 6 categories Reviewed by IRB Chair or a designated member Common in Educational Research- No identifiers </li> <li> Slide 13 </li> <li> Review Categories (cntd) May be Expedited Projects that present no more than minimal risk to the participants, and for minor changes in approved research Has to fit 1 of 7 categories Reviewed and approved by 1 or 2 IRB Committee Members Common in Educational Research for data collection methods that use audio/visual data collection- Retain identifiers </li> <li> Slide 14 </li> <li> Review Categories (cntd) Full Board Review Projects involving more than minimal risk Full Committee meets once per month (Applications must be received at least 10 days before the next meeting date) Researcher are invited to present the research Committee members ask the researcher questions regarding the research and participation of human subjects Vote is taken (in the absence of the researcher) and recommendations are made </li> <li> Slide 15 </li> <li> Review Categories (cntd) Continuing Review Annually for Expedited or Full Board approved applications. Email notifications sent two month prior to approval expiration date. Must complete the Continuing Review Form and attach a copy of the consent form. Same type of review as the original application with some exceptions. </li> <li> Slide 16 </li> <li> Review by Institution Research that has been approved by an IRB may be subject to further appropriate review and approval or disapproval by officials of the institution. However, institutional officials may not approve the research if it has not been approved by an IRB. </li> <li> Slide 17 </li> <li> Criteria for IRB Approval of Research 1. Risks to subjects are minimized sound research design which do not unnecessarily expose subjects to risk, using procedures already being performed on the subjects for diagnostic or treatment purposes. 2. Risks to subjects are reasonable in relation to anticipated benefits, and the importance of the knowledge that may result. 3. Selection of subjects is equitable. </li> <li> Slide 18 </li> <li> Criteria for IRB Approval of Research (cntd) 4. Informed consent is sought. 5. Informed consent is appropriately documented. 6. Plans for monitoring the data collected to ensure the safety of subjects. 7. adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data. 8. additional safeguards to protect vulnerable population (children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons). </li> <li> Slide 19 </li> <li> IRB Requirements IRB must review: Qualification of the PI and collaborators Full description about conflicts of interest A complete description of the proposed research Provisions for the adequate protection of rights and welfare of subjects Compliance with pertinent federal and state laws/regulations and institutional policies </li> <li> Slide 20 </li> <li> HIPAA Requirements Health Insurance Portability and Accountability Act Mandated standards for storage and transmission of healthcare information HHS- The Privacy Rule &amp; Security Rule The research must be HIPAA compliant HIPAA language requirement in consent form PHI- Protected Health Information- 18 identifiers Authorization, Limited Data Set (16 ids) and Data Use Agreement De-identified Health Information- No restrictions </li> <li> Slide 21 </li> <li> Informed Consent Process It is a process and not just a form. It includes: Recruitment materials Verbal instructions (in person or via video, DVD) Written materials Q &amp; A session(s) Documentation of consent by signature </li> <li> Slide 22 </li> <li> Informed Consent Process (cntd) Participants must understand the nature of the research. Participants must be able to knowledgeably and voluntarily decide whether or not to participate. Participants must understand the risks and benefits of participation. The IRB must determine that informed consent will be properly obtained. </li> <li> Slide 23 </li> <li> Elements of Informed Consent Eight Basic Elements 1. Research, Purpose, Procedures (experimental), Expected duration 2. Risks and discomfort 3. Benefit 4. Alternatives procedures (Treatments) 5. Confidentiality of records 6. Medical treatment in case of research related injury 7. Contact Info: Research Qs, Rights Qs, Injury Qs 8. Participation is Voluntary </li> <li> Slide 24 </li> <li> Elements of Informed Consent (cntd) Additional elements, as appropriate 1. Unforeseeable Risk (embryo or fetus) 2. Participation may be terminated by researcher 3. Additional cost to subjects 4. Consequences of early withdrawal by subjects 5. Significant new findings that may affect wiliness to continue participation 6. Approximate number of participants </li> <li> Slide 25 </li> <li> Elements of Informed Consent (cntd) Voluntary Consent if voluntary, free of coercive elements Right to refuse or withdraw with no penalty Unjustifiable pressures occur when persons in authority urge a course of action for a subject Coercion is likely whenever possible sanctions are involved (implied or actual) Undue influence occurs through an offer of an excessive, unwarranted, inappropriate or improper reward Consent process may not involve the use of exculpatory language </li> <li> Slide 26 </li> <li> Elements of Informed Consent (cntd) Comprehension Organized Ample time for consideration Opportunities for questions Lay language appropriate for subject </li> <li> Slide 27 </li> <li> Waiver or Alteration of Consent The IRB may approve a waiver or alteration of the consent process provided: 1. The research involves no more than minimal risk to the subjects; 2. The waiver or alteration will not adversely affect the rights and welfare of the subjects; 3. The research could not practicably be carried out without the waiver or alteration; and 4. Whenever appropriate, the subjects will be provided with additional pertinent information after participation. </li> <li> Slide 28 </li> <li> Important Components of Protection Minimizing Risk Maintaining Confidentiality Maintaining and Destroying Records Maintained for at least 3 years after the completion of the study and then destroyed in a manner that will protect the identity of human subjects. Reporting Adverse Events Related to Research </li> <li> Slide 29 </li> <li> Approved Research Research must be conducted as approved by the IRB. Any changes to original application must also be approved before implementation. Report changes to the IRB via Amendment/Modification form found in the document library of IRBNet IRB approval is valid for a maximum of one year a Continuing Review Form must be submitted to extend the research beyond one year. </li> <li> Slide 30 </li> <li> How to Apply Submit an application via IRBNet accessible through the Human Subjects (IRB) link on the ORA website. All sections of the forms must be completed. The application must include conflict of interest disclosures and CITI training completion reports for all key personnel. All research must be conducted or sponsored by an OU faculty member. Non-tenured track professors and staff members may obtain a Special Permission to sponsor research. </li> <li> Slide 31 </li> <li> What Happens? For research falling within the categories of exempt or expedited review, review may be approved within 2-3 weeks. For research review by the full committee, the primary reviewer may contact you with questions or clarifications regarding the review. You may be asked to attend the meeting if additional clarifications are needed. If approved by the majority of IRB members attending the meeting, you will be notified in writing within a few days. </li> <li> Slide 32 </li> <li> Faculty Responsibilities All investigators conducting research involving human subjects must: Be familiar with Oakland University IRB Guidelines on the ORA website. Complete CITI Training. Faculty training is available periodically throughout the year. Faculty must inform students with whom they are working to read OU Guidelines and complete CITI training. </li> <li> Slide 33 </li> <li> Faculty Responsibilities (cntd) Faculty must approve a student application before it can be reviewed by the IRB. All research must be exempted or approved before it can be conducted. Research must be conducted as described in the approved or exempted application. Research applications must be submitted through IRBNet. </li> <li> Slide 34 </li> <li> Where Do I Find Information? Most information on guidelines, procedures, and submitting research applications can be found at http://www2.oakland.edu/research http://www2.oakland.edu/research Contacts: Dr. Judette Haddad (Regulatory Compliance Coordinator) at haddad@oakland.edu or 248-370-4898.haddad@oakland.edu Dr. Paul Schauert, PhD (IRB Administrator) at schauert@oakland.edu or 248-370-4329 schauert@oakland.edu Dr. Rebecca Sandborg (Director of Regulatory Support) at sandborg@oakland.edu or 248-370-2708. sandborg@oakland.edu Dr. Chris Stiller (IRB Chair) at cstiller@oakland.edu or 248- 364-8661cstiller@oakland.edu </li> <li> Slide 35 </li> <li> Tips: Before you Apply Log in the IRBNet for a user name and password. Be familiar with the questions that are asked on the application. Write the major components of the application (Abstract, Protocol, Consent Form(s), Instruments). Use the suggested language on the consent form template. Include other items given to subjects such as survey questionnaire or advertisements. Allow ample time for the review process to take place. </li> <li> Slide 36 </li> <li> CITI Training Collaborative Institutional Training Initiative https://www.citiprogram.org Register- Choose OU as Participating Institution Three Learner Groups: Faculty Students and Faculty Advisor IRB Members Mandatory Starting January 2011 </li> <li> Slide 37 </li> <li> Questions? </li> </ul>

Recommended

View more >